|
R&D Systems
human recombinant dkk1 ![]() Human Recombinant Dkk1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human recombinant dkk1/product/R&D Systems Average 95 stars, based on 1 article reviews
human recombinant dkk1 - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
R&D Systems
dkk ![]() Dkk, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dkk/product/R&D Systems Average 93 stars, based on 1 article reviews
dkk - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant human dkk 1 protein ![]() Recombinant Human Dkk 1 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recombinant human dkk 1 protein/product/R&D Systems Average 94 stars, based on 1 article reviews
recombinant human dkk 1 protein - by Bioz Stars,
2026-04
94/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant human dkk1 ![]() Recombinant Human Dkk1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recombinant human dkk1/product/R&D Systems Average 93 stars, based on 1 article reviews
recombinant human dkk1 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Oncotarget
Article Title: Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer
doi:
Figure Lengend Snippet: A. - B. β-catenin knockdown significantly suppressed HDGF mRNA expression in HCT116 A. and HT29 B. cells by real-time PCR analysis, respectively; C. - E. β-catenin knockdown inhibited HDGF protein expression in HCT116 cells C. and mainly inhibited nuclear HDGF, β-catenin, c-Myc, cyclin D1, MMP9 and phos-GSK-3β (Ser9) protein expression in HCT116 D. and HT29 E. cells; F. Recombinant Wnt3a and DKK1 increased and decreased HDGF and β-catenin expression in HCT116 cells, respectively; G. - I. Recombinant Wnt3a and DKK1 increased and decreased nuclear and cytoplasmic HDGF, β-catenin, c-Myc, cyclin D1, MMP9 and phos-GSK-3β (Ser9) protein expression in HCT116 G. , I. and LOVO H. cells by Western blot analysis, respectively.
Article Snippet: To further verify the effect of β-catenin on HDGF expression in CRC cells, HDGF and β-catenin protein expressions in HCT116 were induced by 100ng/ml human recombinant Wnt3a (R&D SYSTEMS) and inhibited by 200ng/ml
Techniques: Knockdown, Expressing, Real-time Polymerase Chain Reaction, Recombinant, Western Blot
Journal: Frontiers in Oncology
Article Title: Chondroitin Sulfates Control Invasiveness of the Basal-Like Breast Cancer Cell Line MDA-MB-231 Through ROR1
doi: 10.3389/fonc.2022.914838
Figure Lengend Snippet: CS-E-elicited invasiveness is enhanced by the absence of DKK1. (A) Raw sensor grams. ROR1 was immobilized in a flow cell of a CM5 sensor chip. DKK1 alone (a) , DKK1 premixed with CS-E at a 1:7 molar ratio (b) , and DKK1 premixed with CS-A at a 1:7 molar ration (c) were used as analytes. (B) Response-unit quantification of binding. (C) DKK1 mRNA expression in MDA-MB-231 cells transfected with siDKK1 or control siRNA ( siCont ) measured using qPCR (n=4). Expression data were normalized to those of GAPDH . (D) Invasiveness of DKK1 knocked down MDA-MB-231 cells ( siDKK1 ) or control cells ( siCont ) treated with or without CS-E (n>5). Data were analyzed using a Tukey–Kramer multiple comparison.
Article Snippet: For ROR1 binding assays, WNT5A (0, 0.038, 0.075, 0.15, 0.30, and 0.60 μM), WNT5A/CS-E (0, 0.036/0.25, 0.071/0.50, 0.15/1.0, 0.29/2.0, and 0.57/4.0 μM),
Techniques: Binding Assay, Expressing, Transfection, Control, Comparison
Journal: Frontiers in Oncology
Article Title: Chondroitin Sulfates Control Invasiveness of the Basal-Like Breast Cancer Cell Line MDA-MB-231 Through ROR1
doi: 10.3389/fonc.2022.914838
Figure Lengend Snippet: Schematic of CS-E enhancement of invasive activity of the triple-negative breast cancer MDA-MB-231 cell line. CS chains bind WNT5A and ROR1 through E units, signaling cancer cells to activate JNK1. Decreasing E units by knockdown of CHST11 and CHST15 inhibits WNT5A−ROR1−JNK signaling. DKK1 suppresses CS tumor promoting activity by binding to E units.
Article Snippet: For ROR1 binding assays, WNT5A (0, 0.038, 0.075, 0.15, 0.30, and 0.60 μM), WNT5A/CS-E (0, 0.036/0.25, 0.071/0.50, 0.15/1.0, 0.29/2.0, and 0.57/4.0 μM),
Techniques: Activity Assay, Knockdown, Binding Assay